about
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migrationThe antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseasesEpithelial Anion Transport as Modulator of Chemokine SignalingThe Evolution of Cystic Fibrosis CareActivity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosisContribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputumInflammasome-mediated IL-1β production in humans with cystic fibrosisApoptosis and the airway epitheliumMultimodality molecular imaging of the lung.Microstructural alterations of sputum in cystic fibrosis lung disease.Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.High-Dose Ibuprofen in Cystic Fibrosis.Pathology of gastrointestinal organs in a porcine model of cystic fibrosis.Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.The Pseudomonas aeruginosa autoinducer 3O-C12 homoserine lactone provokes hyperinflammatory responses from cystic fibrosis airway epithelial cellsReduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis.Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.The blood neutrophil to lymphocyte ratio correlates with clinical status in children with cystic fibrosis: a retrospective studyProtein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.RNA sequencing from human neutrophils reveals distinct transcriptional differences associated with chronic inflammatory states.Host-pathogen interplay in the respiratory environment of cystic fibrosis.Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.Host-microbiome interactions in acute and chronic respiratory infections.Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection.The Th17 pathway in cystic fibrosis lung disease.Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia.X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.Acute inflammation induces insulin-like growth factor-1 to mediate Bcl-2 and Muc5ac expression in airway epithelial cells.Reducing bias in bacterial community analysis of lower respiratory infections.Effects of Quorum Sensing Systems on Regulatory T Cells in Catheter-Related Pseudomonas aeruginosa Biofilm Infection Rat Models.Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation.Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction.Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.Hyperinflammation in airways of cystic fibrosis patients: what's new?Progress in cystic fibrosis and the CF Therapeutics Development NetworkVitamin D deficiency and chronic lung disease[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.
P2860
Q21146674-E6779A0C-73C7-45BA-B034-65808D96DB4AQ24655891-9D551A5B-9878-470C-9CBC-A92269C58269Q26744381-FE27592D-2B2B-4A20-9958-2BB764EE40E5Q26999299-AAE16FC2-50F6-4D5B-991F-85D1C50BE765Q28475562-7BC0E018-F5A5-47BD-A0FA-4BD0A3B745FEQ28482121-F571F26B-E018-4214-8DBF-FD14749F78F5Q28483902-FD8A349A-6608-43F9-B79B-ECDB96331163Q28741414-F6A723FF-429D-462A-A2A1-AC20C7DAE207Q30364295-59EE1F50-3AC1-4D40-B098-6F67C65D267CQ30826846-5010F89E-4E5A-484E-BADD-DACE9CDA8DFAQ33624180-F065E683-77E1-47F4-91B1-A1D057422423Q33678000-0EAED814-2FE4-4250-8C84-083FDB66F413Q33703755-3FADC02D-DD14-4CF5-B952-8B8C7BD6AD82Q33749315-E75C091F-C578-4073-B91E-A2381E2C32B9Q33794333-90318CD5-819B-4918-B0AE-DCDED147F0A7Q33815764-F0775420-2DDF-4A13-A54F-358CC5F20142Q34309058-C92EADE0-7A07-4DCE-89F7-CACF600E4A81Q34358489-BBF1FDA0-A9DE-44DD-B498-169A3F361E4CQ35009766-A85DCEFA-F1D8-4205-A5FC-2C7E36D5A3BFQ35043552-FA5FE33A-EC68-474D-A457-57D76CC42B44Q35043722-F892C8C2-844A-4F55-8C09-1565EE563B48Q35756615-F6182DB9-D493-4AE6-8EDD-B1AF6CCAEBA5Q35799736-B1C9F110-8CEA-4A04-924B-662AA267B9BEQ35946121-24162CF8-1CE5-4B35-A3BE-F2082FFB4928Q35955467-EA4F428A-37F6-4C01-9E23-B93EA2F6F8B5Q36014860-29A98D08-D0D4-4F2B-90B9-9178F1662695Q36054539-DDB83D36-F036-4616-A369-A4E4BDD75760Q36356523-68883CF8-A598-43F7-9DDF-38AAB9AED3A9Q36516884-54A689B1-40EB-4009-AFFF-EEA3A6A364F2Q36539588-E7CD90C2-0040-44A7-9AB7-244B60DDF2D5Q36702276-06592B64-058A-4515-BF69-AFF41F15B89BQ36741701-401D5BC7-D345-49EF-9194-219BB1AA66D2Q36802466-45D584CD-722D-4DA5-AF51-EF4A16E6E416Q36937623-742CA082-E0BB-42C3-9238-BC1800D51646Q37079153-70CD2E59-71CF-4623-B302-21E377660FD3Q37182109-F79CD95E-06BC-4819-82BE-4F01DC9F501FQ37206228-F07C0BC5-FEEC-4899-A8D7-3098C4A2D999Q37209004-F36DC813-A9C6-4696-9ACD-F6B178788271Q37252704-4ABF1E6D-C3C7-412D-A640-BAA98F3BCBAAQ37343748-95DC72C8-EF06-49A3-9DB2-E7FB5424A47B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Airway inflammation in cystic fibrosis.
@en
Airway inflammation in cystic fibrosis.
@nl
type
label
Airway inflammation in cystic fibrosis.
@en
Airway inflammation in cystic fibrosis.
@nl
prefLabel
Airway inflammation in cystic fibrosis.
@en
Airway inflammation in cystic fibrosis.
@nl
P2093
P356
P1433
P1476
Airway inflammation in cystic fibrosis.
@en
P2093
Arnon Elizur
Carolyn L Cannon
Thomas W Ferkol
P304
P356
10.1378/CHEST.07-1631
P407
P577
2008-02-01T00:00:00Z